scorecardresearch
Add as a preferred source on Google
Tuesday, February 24, 2026
TopicVaccine

Topic: Vaccine

Stricter vaccine approval process is the last thing the US needs

ThePrint view on the most important issues.

Flagging bird flu’s ‘pandemic potential’, ICMR calls on private firms to collaborate on human vaccine

India's apex health research body has warned that H5N1 infection in humans has a high case fatality rate, exceeding 50 percent.

India’s Vaccine Regulation System Meets WHO Standards

A review was carried out by international experts between 16 and 20 September.

ICMR back in race to offer world’s 1st vaccine for deadly shigella, to tie up with Indian manufacturer

ICMR had in 2019 licensed technology for scaling up and commercialisation of its shigella vaccine to MSD-Wellcome Trust Hilleman Laboratories, but the deal fell through.

BRICS Vaccine Research Center launched in India

New Delhi: In a statement issued after the meeting, Union Health Secretary Apurva Chandra said that the BRICS Vaccine Research and Development Centre, established...

Government signs MoU with UNDP for capacity building and digitalization of vaccine cold chain management

This partnership aims to enhance the digitalization of vaccine cold chain management, capacity building, and communication planning in India.

Panel will keep watch for violation of new drug marketing code, says pharma secretary

Implemented in March, UCPMP 2024 will look into complaints regarding unethical practices in sector. Code gains significance given that Patanjali is facing SC heat for misleading ads.

Global panel calls for scaling up cholera vaccine supply to combat ongoing upsurge in cases

International Coordinating Group (ICG) on Vaccine Provision (ICG) noted that 473,000 cases of cholera were reported to the WHO in 2022.

Govt for the first time considers pre-exposure anti-rabies shots for kids as dog bite cases ‘rise’

National Centre for Disease Control formed panel to discuss such vaccinations through Universal Immunization Programme. Evidence being gathered to present to NTAGI, it is learnt.

World’s 1st vaccine against chikungunya primed for launch in India, says French drugmaker Valneva

VLA1553, commercially known as Ixchiq, has received USFDA clearance and will be launched in India — which has seen high number of chikungunya cases — after ‘regulatory talks with DCGI’.

On Camera

Where does the law stand on Himanta Biswa Sarma’s video of ‘shooting’ Muslims?

Assam CM Himanta Biswa Sarma's Hindu-Muslim polarisation is clearly done to maximise the odds of winning. But an important legal question is: does it expose him to legal liability?

FY23 chosen as new base for India’s GDP as it was 1st ‘normal economic year’ in a while—MoSPI secy

FY 2022-23 was the first normal economic year in recent years, said Saurabh Garg, Secretary of the Ministry of Statistics and Programme Implementation, in an interview with ThePrint.

IAF’s Tejas fleet undergoes ‘maintenance check’, decision on airframe yet to be taken

The 7 February incident involving Tejas aircraft caused severe damage to its frame. IAF and HAL are working together as part of the Board of Inquiry (BoI) to probe the incident.

No country is ever fully sovereign. Cold War era taught India its real meaning

India’s fraught neighbourhood places multiple constraints on its strategic choices. It leaves no time to take a deep breath, lean back and reset.